These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18401778)
21. Factorial design-based optimization of the formulation of isosorbide-5-mononitrate microcapsules. Farivar M; Kaş HS; Oner L; Hincal AA J Microencapsul; 1993; 10(3):309-17. PubMed ID: 8377088 [TBL] [Abstract][Full Text] [Related]
22. Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G. Ivić B; Ibrić S; Cvetković N; Petrović A; Trajković S; Djurić Z Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):947-9. PubMed ID: 20606343 [TBL] [Abstract][Full Text] [Related]
23. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC. Sankalia JM; Sankalia MG; Mashru RC J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362 [TBL] [Abstract][Full Text] [Related]
24. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling. Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015 [TBL] [Abstract][Full Text] [Related]
25. Modulation of a pulsatile release drug delivery system using different swellable/rupturable materials. El-Maradny HA Drug Deliv; 2007 Nov; 14(8):539-46. PubMed ID: 18027184 [TBL] [Abstract][Full Text] [Related]
26. [Prescription screening of total coumarins of Angelica dahurica var. formosana extended action tablets based on artificial neural network]. Li L; Li SF; He YX Zhong Yao Cai; 2014 May; 37(5):875-80. PubMed ID: 25335297 [TBL] [Abstract][Full Text] [Related]
27. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Khaled SA; Burley JC; Alexander MR; Roberts CJ Int J Pharm; 2014 Jan; 461(1-2):105-11. PubMed ID: 24280018 [TBL] [Abstract][Full Text] [Related]
28. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release. Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548 [TBL] [Abstract][Full Text] [Related]
29. [Application of an artificial neural network in the design of sustained-release dosage forms]. Wei XH; Wu JJ; Liang WQ Yao Xue Xue Bao; 2001 Sep; 36(9):690-4. PubMed ID: 12580110 [TBL] [Abstract][Full Text] [Related]
30. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Yang B; Wei C; Yang Y; Wang Q; Li S Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692 [TBL] [Abstract][Full Text] [Related]
31. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. Chen Y; McCall TW; Baichwal AR; Meyer MC J Control Release; 1999 May; 59(1):33-41. PubMed ID: 10210720 [TBL] [Abstract][Full Text] [Related]
32. Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Chopra S; Patil GV; Motwani SK Eur J Pharm Biopharm; 2007 Apr; 66(1):73-82. PubMed ID: 17056238 [TBL] [Abstract][Full Text] [Related]
33. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling. Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702 [TBL] [Abstract][Full Text] [Related]
34. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipients. Majid Khan G; Zhu JB J Control Release; 1998 Dec; 56(1-3):127-34. PubMed ID: 9801436 [TBL] [Abstract][Full Text] [Related]
35. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118 [TBL] [Abstract][Full Text] [Related]
36. Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release. Franc A; Sabadková D; Neumann D; Pavloková S; Kopecká P; Muselík J Pharm Dev Technol; 2016 Nov; 21(7):867-874. PubMed ID: 26334252 [TBL] [Abstract][Full Text] [Related]
37. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Roy P; Shahiwala A Eur J Pharm Sci; 2009 Jun; 37(3-4):363-9. PubMed ID: 19491027 [TBL] [Abstract][Full Text] [Related]
38. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study. Qi X; Jiang Y; Zhang H; Wu Z J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700 [TBL] [Abstract][Full Text] [Related]
39. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. Hariharan M; Wowchuk C; Nkansah P; Gupta VK Drug Dev Ind Pharm; 2004 Jul; 30(6):565-72. PubMed ID: 15285329 [TBL] [Abstract][Full Text] [Related]
40. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables. Mostafa HF; Ibrahim MA; Sakr A Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]